Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02452242
What this trial is testing

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Who this might be right for
Human Immunodeficiency Virus Infections
Abivax S.A. 70
Testing effectiveness (Phase 2)Study completedNCT00560313
What this trial is testing

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

Who this might be right for
Meningococcal Disease
Novartis Vaccines 54
Testing effectiveness (Phase 2)Looking for participantsNCT06682988
What this trial is testing

Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Who this might be right for
Advanced High-Grade Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancers
AbbVie 110
Testing effectiveness (Phase 2)Ended earlyNCT00760929
What this trial is testing

The Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 171
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Testing effectiveness (Phase 2)Study completedNCT00700206
What this trial is testing

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome (MDS)
Telik 86
Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Testing effectiveness (Phase 2)Study completedNCT00067808
What this trial is testing

Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center 128
Early research (Phase 1)Study completedNCT00136578
What this trial is testing

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Who this might be right for
Solid Tumours
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT03000348
What this trial is testing

The Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

Who this might be right for
Cystic Fibrosis
NovaBiotics Ltd. 91
Large-scale testing (Phase 3)Study completedNCT00052026
What this trial is testing

Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
Shaddy, Robert, M.D. 161
Testing effectiveness (Phase 2)Study completedNCT00185302
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 28
Large-scale testing (Phase 3)Active Not RecruitingNCT06736041
What this trial is testing

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal Immunization
Sanofi Pasteur, a Sanofi Company 1,714
Very early researchActive Not RecruitingNCT05329961
What this trial is testing

Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

Who this might be right for
Human Papilloma Virus
Boston Medical Center 155
Large-scale testing (Phase 3)Study completedNCT04016714
What this trial is testing

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 1,191
Early research (Phase 1)Study completedNCT00118456
What this trial is testing

Study of Oral AEE788 in Adults With Advanced Cancer

Who this might be right for
Cancer
Novartis Pharmaceuticals 189
Testing effectiveness (Phase 2)Study completedNCT00990535
What this trial is testing

High Dose Somatostatin Analogues in Neuroendocrine Tumors

Who this might be right for
Respiratory Tract NeoplasmsThymic NeoplasmsPancreatic Neoplasms+2 more
Federico II University 28
Early research (Phase 1)Study completedNCT02345382
What this trial is testing

Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia

Who this might be right for
Leukemia
Bayer 42
Early research (Phase 1)Study completedNCT02662712
What this trial is testing

Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)

Who this might be right for
HealthyHepatitis, Chronic
Janssen Sciences Ireland UC 87
Post-approval studies (Phase 4)Study completedNCT01294605
What this trial is testing

Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 460
Next Page